1. Stocks
  2. Solara Active Pharma Sciences Ltd.
  3. Swot
swot-logo

Solara Active Pharma Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Solara Active Pharma Sciences Ltd. has 13 Strengths, 12 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with decreasing Promoter pledge

Stock gained more than 20% in one month

RSI indicating price strength

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

Negative Breakdown First Support (LTP < S1)

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Declining Revenue every quarter for the past 3 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Profit to Loss Companies

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

High promoter stock pledges

Top Losers

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Promoters increasing shareholding QoQ

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Decline in Quarterly Net Profit with falling Profit Margin (YoY)